Skip to main content
. 2020 Aug 13;2020(8):CD005552. doi: 10.1002/14651858.CD005552.pub3

NCT02744131.

Study name OCP vs metformin for Improvement in clinical symptoms and metabolic markers in Indian PCOS women (OCP)
Methods Randomised controlled trial
Participants Inclusion criteria
‐ Women with PCOS diagnosed by Rotterdam criteria
‐ Age > 16 or menarche of at least 2 years up to age 40.
‐ Diagnosed by Rotterdam Anovulation Ferriman‐Gallwey score ≥ 8 or Total testosterone ≥ 40 ngm/dL ovarian volume ≥ 10 cc BMI > 23
‐ Women not attempting pregnancy at present.
Exclusion criteria
‐ Women with PCOS with BMI ≤ 23
‐ Undergoing any treatment for acne hirsutism. Including Homeopathic, Ayurvedic
‐ Known diabetic or hypertension .
Interventions Group a: OCP (Ethinyl Estradiol 20 mcg/ 2 mg Cyproterone acetate).
Group b: MET 1500 g/day
Outcomes Improvements in menstrual cycle
Improvement in hirsutism
Improvement in acne score
Weight loss following treatment
Reduction in total testosterones
Reduction in serum fasting insulin
Improvements in lipid profile
Starting date 04/2016
Contact information Responsible party: Sujata Kar,Odisha, India
Notes Recruiting